HAILU DEMISSACHEW

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ROME, GA NPI 1356401616

General Payments — all program years on this page

$3,029.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 161
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $431.52 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $382.3017
Education $49.222

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $262.9915
2019 $506.8221
2020 $153.3912
2021 $333.0911
2022 $561.5834
2023 $780.0549
2024 $431.5219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104682707 AstraZeneca Pharmaceuticals LP $21.39 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561767 Amgen Inc. $31.43 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561769 Amgen Inc. $31.50 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561771 Amgen Inc. $18.15 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111561773 Amgen Inc. $17.72 07/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117976888 Boehringer Ingelheim Pharmaceuticals, Inc. $16.88 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118883985 Otsuka America Pharmaceutical, Inc. $26.28 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124040331 Vifor Pharma, Inc. $16.94 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145063706 Mallinckrodt Hospital Products Inc. $37.10 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145829857 AKEBIA THERAPEUTICS INC $15.98 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145833335 AKEBIA THERAPEUTICS INC $24.61 09/19/2024 Education Undisputed 01/23/2026 View at CMS
1145833931 AKEBIA THERAPEUTICS INC $24.61 10/08/2024 Education Undisputed 01/23/2026 View at CMS
1146677800 Ardelyx, Inc. $24.21 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149919314 Travere Therapeutics, Inc. $19.22 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150123691 SHIELD THERAPEUTICS INC $28.87 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150679029 Aurinia Pharma U.S., Inc. $29.73 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154204400 Fresenius USA Marketing, Inc. $13.19 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154204402 Fresenius USA Marketing, Inc. $14.87 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154204404 Fresenius USA Marketing, Inc. $18.84 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.